相关实验视频

Updated: Jul 2, 2025

Adapting Human Videofluoroscopic Swallow Study Methods to Detect and Characterize Dysphagia in Murine Disease Models

Adapting Human Videofluoroscopic Swallow Study Methods to Detect and Characterize Dysphagia in Murine Disease Models

Published on: March 1, 2015

滴水可能与多发性硬化症的消化不良症状有关

Merve Sapmaz Atalar¹, Gençer Genç², Serpil Bulut²

¹Department of Speech and Language Therapy, Hamidiye Faculty of Health Sciences, University of Health Sciences, Istanbul, Turkey. merve.sapmaz@sbu.edu.tr.

|February 18, 2024

概括

多发性硬化症 (MS) 中的唾液流与失足症有关,而不是过多的唾液流. 多发性硬化症调查问卷 (DYMUS) 中的食障碍得分是患有多发性硬化症 (PwMS) 患者流口水的关键风险因素.

科学领域:

神经学神经学
临床研究临床研究

背景情况:

唾液流 (sialorrhea) 是患有多发性硬化症 (PwMS) 的人群常见但经常被忽视的症状.
在PwMS中病的根本原因仍然不太清楚,需要对潜在的风险因素进行进一步调查.

研究的目的:

识别和评估与多发性硬化症患者的唾液流动相关的潜在风险因素.
探索流口水与MS相关的其他症状,如食障碍和疲劳之间的关系.

主要方法:

一项比较研究涉及20个带有唾液的PwMS和19个没有唾液的PwMS.
使用了多发性硬化症问卷 (DYMUS) 中的消化不良,疲劳严重程度量表 (FSS) 和客观的唾液流量测量.
使用单变量和多变量逻辑回归模型来分析风险因素.

主要成果:

流口水的PwMS显示DYMUS得分和下下/下舌唾液流量明显更高.
疲劳严重程度尺度 (FSS) 和唾液流量被确定为单变量分析中的风险因素.
在多变量分析中,多发性硬化症调查问卷 (DYMUS) 的食障碍 (Dysphagia in Multiple Sclerosis Questionnaire) 成为唾液流出的唯一显著风险因素.

结论:

这项研究表明,在患有多发性硬化症的人中,流口水和消化不良症状之间存在显著联系.
正如DYMUS得分所指出的那样,缺食症是PwMS中流的主要危险因素.
这些发现为了解多发性硬化症的唾液和指导治疗策略提供了基础.

关键词:

流的流的流的消化不良症消化不良症过多的唾液流动多发性硬化症是多发性硬化症.

更多相关视频

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on: November 9, 2016

Minimally Invasive Murine Laryngoscopy for Close-Up Imaging of Laryngeal Motion During Breathing and Swallowing

Minimally Invasive Murine Laryngoscopy for Close-Up Imaging of Laryngeal Motion During Breathing and Swallowing

Published on: December 1, 2023

相关概念视频

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...